淋巴瘤治疗疗效评估和PETCT应用进展课件

单击此处编辑母版标题样式,单击此处编辑母版文本样式,第二级,第三级,第四级,第五级,*,*,淋巴瘤治疗的疔效评估,及 PET-CT的作用,美罗华市场部,二零一三年八月,目录,淋巴瘤疗效评估标准的变,IHP淋巴痛疗效评估标准介绍,PET(PET/cT)的发展对淋巴瘤疔效评估标准的影响,.屐:12进,目录,淋巴瘤疗效评估标准的演变,IHP淋巴痛疗效评估标准介绍,PET(PET/cT)的发展对淋巴瘤疔效评估标准的影响,.屐:12进,999年之前没有统一的淋巴瘤疗效评估标准,2019年之前,ECOG、 CALGB等主要淋巴瘤研究机构,没有统一的淋巴瘤疗效评估标准,1. Response Criteria for NHL Used by Interna,Group,CHnical Trials Group Disappearance of all dis,ncrease by 25% in longest lamster,Must last weeks or unconfinEd CR,Assessable disease progression,Cancer and Leukemia Group B,anse e all dses乡,M+时 i-30% dccrease in Il,Mediasinalonrus after50X,positive. now must be 2 50%, decrease in sPD,crease by 25% in SPD or,appearance of all d sease inormal Spleen 5 cm blm must become,RElapse: new disease aner CR Or PD,en5 cm deerease by 50%,Normal liver /spleen biopsy if was Must las 2 41,egative uri lateral bone marrow,Cheson BD, e a. Repon of an Intemet onal workshop to standard ee Respense Cr iteria for Nen-Hodekims Lymphomas Journa of Chencai Oneo,1244-12,疗效评估标准的不统一带来明显的局限性,不符合淋巴瘤的,生物学和治疗反应,给不同研究结果之间,的分析/比较带来困扰,